Solutions

Clinical solutions

Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions

Consulting & Commercial

Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data

Case studies
Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

Technologies
Technology solutions from early phase through to post-marketing.
Sectors

Sectors

ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

Read more

Biotech Government and Public Health Medical Device Pharmaceuticals

Biotech
Developing transformative therapies requires a flexible approach.

ICON and You
Partners making a difference.
Therapeutics

Therapeutics

Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology

Cross-therapeutics

Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health

Obesity
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

Therapeutics insights
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Insights

Insights

Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel

Building a comparative evidence base using network meta-analysis
Methods, implementation and reporting

Download 2025 Global and China biotech sector survey reports
Two new reports of surveys of 260+ Global and China biotech leaders have just been released

From bottlenecks to breakthroughs
Human-centred strategies for faster study starts
News & Events

News & Events

ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

Read more

Press releases In the News Mediakit Awards Events Webinars Social media

ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
Watch the webinar.

Riding the data wave: How pharma can navigate disruptions in open claims
Watch the webinar.
About ICON

About ICON

Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality

ICON for

Patients Volunteers Investigators Jobs & Careers Investors Suppliers

Sustainability, charity, inclusion and belonging
ICON Cares is our commitment to making a positive impact on our people, environment and our community.

ICON at a glance
Delivering successful outcomes across the clinical development lifecycle.

Careers
Investors
Contact
日本語
简体中文

Home
News & Events
Social media

Social media

Showing 721 - 732 of 955 results for "*"

ICON will be participating in ACOP 2025 in Aurora, Colorado, where we will introduce Yi Z., our new Scientific Director of PK in the Pharmacometrics Department. Yi brings extensive expertise in PK/PD modeling, disease ...

9 Oct

ICON Plc

Visit booth 409 at #RAPSConvergence2025 to meet ICON’s Regulatory Affairs team. Stop by to discuss how we can support your regulatory strategy, CMC, project management, medical device and post-market requirements across ...

8 Oct

ICON Plc

ICON is proud to be a sponsor at the upcoming #OCTNordics conference, taking place on 21–22 October in Copenhagen, Denmark. Join us at booth #41 to connect with our experts and explore how ICON is driving innovation and...

8 Oct

ICON Plc

ICON is proud to be a sponsor at the upcoming #OCTNordics conference, taking place on 21–22 October in Copenhagen, Denmark. Join us at booth \#41 to connect with our experts and explore how ICON is driving innovation an...

8 Oct

ICON Plc

On 28 October at 2:15 PM, ICON’s Suzanne Jansen, Head of QC Accelerated Pharmaceutical Solutions will present a session on Clinical innovation: Enabling dosing flexibility in early phase trials, an integrated CMC and man...

Patient recruitment strategies need to evolve to ensure the best data from a wider range of patients. Meet ICON experts at #ESMO25, booth #3034 to learn how our strategic solutions and innovative methods help reduce pati...

8 Oct

ICON Plc

Patient recruitment strategies need to evolve to ensure the best data from a wider range of patients. Meet ICON experts at #ESMO25, booth \#3034 to learn how our strategic solutions and innovative methods help reduce pat...

8 Oct

ICON Plc

ICON is proud to be recognised as one of Marksmen Daily's ‘Most Preferred Workplaces for Women 2025-26’ in India. This distinction highlights our dedication to creating an environment where women feel valued, supported, ...

Discover the value of strategic early engagement during Stacey Flattery Vice President, General Partner, speaker session on Wednesday, 15 October at 11:30am at #OCTNewEngland2025. Learn how to optimize clinical outsourc...

7 Oct